Guest Speaker: Professor Gabriel Leung, Dean of Medicine, Helen and Francis Zimmern Professor in Population Health and Chair of Public Health Medicine at the University of Hong Kong (HKU)
Technology assessment, broadly defined as the evaluation and monitoring of relative effectiveness and cost in health care delivery, began with Archie Cochrane's Effectiveness and Efficiency: Random Reflections on Health Services published in the same year as the speaker's birth in 1972. Since then the field has built on theoretical foundations drawn from epidemiology and economics, found popular expression in the evidence-based practice movement and translated into the everyday work of agencies such as UK NICE, Thai HiTAP, US PCORI and Australia's PBAC, TGA and MSAC. As the field has developed and become inextricably integrated into decision making, however, the chorus of charges against "rationing" even "death panels" from vested interests and the body politik is coming to a deafening crescendo.
In the current anti-elitist climate where the postmodern fluidity of truth and facts is taken to an unprecedented level, I posit that the underpinnings to this evaluative science would require a fundamental rethink if it were to survive the present existential challenge. I illustrate the evolution of the field with examples in mammography screening and diabetes care and conclude with a possible set of transformative responses for the future.
Please join Professor Gabriel Leung as he delivers the 2018 S T Lee Lecture.**
Professor Gabriel Leung is the fortieth Dean of Medicine (2013-), Helen and Francis Zimmern Professor in Population Health and Chair of Public Health Medicine at the University of Hong Kong (HKU). A specialist in public health medicine, Leung's interdisciplinary work revolves around topics that have major population health impact locally, where Hong Kong is a reliable and unique epidemiologic sentinel for China, or where the SAR is best placed to address the fundamental science at hand globally.
Leung is one of Asia's leading epidemiologists, having authored more than 450 scholarly papers with an h-index of 55. His research defined the epidemiology of two novel viral epidemics, namely SARS-CoV in 2003 and influenza A(H7N9) in 2013. He also led Hong Kong government's efforts against pandemic A(H1N1) in 2009. Leung leads several large-scale longitudinal cohorts tracking tens of thousands of lives to study the fundamental causes of non-communicable conditions and to explain the health impacts of contemporary social phenomena.
His team is the government's health accountant and projects health care human resources needs into the future. Regionally, Leung has tirelessly worked to build capacity throughout the Asia Pacific. Learn More
**The University of Sydney, by way of a gift, established the S.T. Lee Lecture Fund in 2008 to invite a distinguished scholar and/or practitioner on the subject of contemporary health policy to deliver an annual lecture. The S.T. Lee Lecture is named for Seng Tee Lee, a business executive and noted philanthropist. Dr Lee is director of the Lee group of companies in Singapore and of the Lee Foundation.